David M. Knott portfolio

Latest available portfolio: Q3 2021 · Holdings as of · Filed ·
$250.82MFull value: $250,816,000 · USD · 30 Sep 2021
in Form 13F holdings
See latest portfolio changes

Quarterly portfolio filings

Choose a quarter to see holdings and changes. Newer portfolio dates appear first.

Estimated additions and reductions require qualified adjacent-quarter disclosures and use filing-derived prices. A dash means unavailable; these estimates are not actual trade proceeds or costs.

Quarter Holdings SEC-reported value Est. additions Est. reductions Est. net Top Holdings Form Type Accepted by SEC
Q3 2021 151 $250,816,000 — — — CLMT, APO, GOOG, FTAI, LGND 13F-HR 12 Nov 2021, 09:13
Q2 2021 148 $262,902,000 — — — CLMT, APO, FTAI, MITAU, GOOG 13F-HR 13 Aug 2021, 08:26
Q1 2021 130 $232,632,000 — — — CLMT, UPLD, APO, FTAI, GOOG 13F-HR 13 May 2021, 13:01
Q4 2020 110 $220,913,000 — — — LGND, UPLD, FTAI, APO, DNMR 13F-HR 12 Feb 2021, 14:26
Q3 2020 98 $170,440,000 — — — LGND, UPLD, APO, FTAI, SRCL 13F-HR 13 Nov 2020, 08:43
Q2 2020 92 $183,186,000 — — — LGND, SRCL, APO, UPLD, FTAI 13F-HR 12 Aug 2020, 09:16
Q1 2020 121 $158,454,000 — — — LGND, SRCL, APO, UPLD, GOOG 13F-HR 13 May 2020, 09:56
Q4 2019 114 $246,695,000 — — — LGND, FTAI, SRCL, UPLD, APO 13F-HR 14 Feb 2020, 13:26
Q3 2019 119 $238,031,000 — — — LGND, SRCL, UPLD, FTAI, APO 13F-HR 12 Nov 2019, 12:42
Q2 2019 111 $237,063,000 — — — LGND, UPLD, FTAI, SRCL, APO 13F-HR 12 Aug 2019, 13:45
Q1 2019 110 $250,882,000 — — — LGND, UPLD, FTAI, SRCL, MPLX 13F-HR 13 May 2019, 07:50
Q4 2018 101 $212,802,000 — — — LGND, PFE, UPLD, MPLX, CFFN 13F-HR 12 Feb 2019, 14:35
Q3 2018 106 $307,874,000 — — — LGND, PFE, DVMT, UPLD, MPLX 13F-HR 13 Nov 2018, 07:55
Q2 2018 109 $266,750,000 — — — LGND, PFE, UPLD, DVMT, CFFN 13F-HR 13 Aug 2018, 11:52
Q1 2018 107 $242,219,000 — — — LGND, PFE, UPLD, CFFN, FTAI 13F-HR 11 May 2018, 15:43
Q4 2017 110 $250,760,000 — — — LGND, PFE, CFFN, MIC, MSFT 13F-HR 13 Feb 2018, 11:20
Q3 2017 108 $233,747,000 — — — LGND, PFE, CFFN, MSFT, ABBV 13F-HR 13 Nov 2017, 12:55
Q2 2017 90 $237,738,000 — — — LGND, PFE, CFFN, ABBV, MSFT 13F-HR 11 Aug 2017, 09:19
Q1 2017 79 $207,822,000 — — — LGND, PFE, CFFN, APC, ABBV 13F-HR 12 May 2017, 07:08
Q4 2016 70 $198,702,000 — — — LGND, PFE, CFFN, APC, ABBV 13F-HR 13 Feb 2017, 10:25
Q3 2016 65 $193,724,000 — — — LGND, PFE, CFFN, APC, ABBV 13F-HR 10 Nov 2016, 12:09
Q2 2016 83 $434,096,735 — — — LGND, PFE, APC, SM, SWN 13F-HR 12 Aug 2016, 13:01
Q1 2016 82 $375,322,306 — — — LGND, PFE, APC, CNQ, HES 13F-HR 12 May 2016, 08:02
Q4 2015 81 $364,861,196 — — — LGND, PFE, APC, PXD, CXO 13F-HR 12 Feb 2016, 09:56
Q3 2015 80 $346,748,062 — — — LGND, PFE, APC, XEC, CXO 13F-HR 12 Nov 2015, 08:22

Showing 1-25 of 32 filings.

Manager details and filing context
Latest 13F filing
Q3 2021 - 12 Nov 2021
Latest reported 13F value
$250,816,000
Largest 13F holdings
CLMT APO GOOG FTAI LGND UPLD MITA KDMN MDWT GREE MITAW TWLV
+8 morePFE GLHA FSK KW EBC REGN Trillium Therapeutics Inc. LOKM
Manager location
Syosset, NY
Holdings Value
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .